Why is Disulfiram superior to acamprosate in the routine clinical setting? a retrospective long-term study in 353 alcohol-dependent patients

Alcohol and Alcoholism

Volumn 45, Issue 3, 2010, Pages 271-277

  Diehl, Alexander ^a   Ulmer, Lisa ^b   Mutschler, Jochen ^b   Herre, Hans ^b   Krumm, Bertram ^b   Croissant, Bernhard ^b   Mann, Karl ^b   Kiefer, Falk ^b  

^a KLINIKUM BRAUNSCHWEIG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; DISULFIRAM;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; ATTITUDE TO HEALTH; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DETOXIFICATION; DISEASE DURATION; DRUG COST; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SELF REPORT; SEX DIFFERENCE; SLEEP DISORDER; TREATMENT OUTCOME;

ADULT; ALCOHOL DETERRENTS; ALCOHOLISM; BREATH TESTS; DISULFIRAM; FEMALE; GERMANY; HUMANS; KAPLAN-MEIERS ESTIMATE; LONG-TERM CARE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; TAURINE; TEMPERANCE; TREATMENT OUTCOME;

EID: 77949379574     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agq017     Document Type: Article

References (36)

1. Anton RF. (2001) Pharmacologic approaches to the management of alcoholism. J Clin Psychiatry 62:11-7.
2. Anton RF, O'Malley SS, Ciraulo DA et al. (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295:2003-17
3. Berglund M, Thelander S, Salaspuro M et al. (2003) Treatment of alcohol abuse: an evidence-based review. Alcohol Clin Exp Res 27:1645-56
4. Bouza C, Angeles M, Munoz A et al. (2004) Effcacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 99:811-28
5. Brewer C. (1992) Controlled trials of Antabuse in alcoholism: the importance of supervision and adequate dosage. Acta Psychiatr Scand Suppl 369:51-8
6. Brewer C. (1993) Recent developments in disulfiram treatment. Alcohol Alcohol 28:383-395
7. Carroll K, Ziedonis D, O'Malley SS et al. (1993) Pharmacologic interventions for alcohol and cocaine abusing individuals: a controlled study of disulfiram vs. naltrexone. Amer J Addict 2:77-9
8. Chick J, Gough K, Falkowski W et al. (1992) Disulfiram treatment of alcoholism. Br J Psychiatry 161:84-9
9. Chick J. (1998) Treatment of alcoholic violent offenders: ethics and effcacy. Alcohol Alcohol 33:20-5
10. Chick J. (1999) Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Saf 20:427-35
11. Chick J. (2004) Disulfiram: cautions on liver function; how to supervise. Addiction 99:25-8
12. Chick J, Lehert P, Landron F. (2003) Does acamprosate improve reduction of drinking as well as aiding abstinence? J Psychopharmacol 17:397-402
13. de Sousa A, de Sousa A. (2004) A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. Alcohol Alcohol 39:528-31
14. de Sousa A, de Sousa A. (2005) An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 40:545-8
15. Diehl A, Croissant B, Batra A et al. (2007) Alcoholism in women: is it different in onset and outcome compared to men? Eur Arch Psychiatry Clin Neurosci 257:344-51
16. Diehl A, Mann K. (2007) Pharmacological relapse prevention in alcohol and tobacco dependence. Internist (Berl) 48:79-88
17. Ehrenreich H, Krampe H. (2004) Does disulfiram have a role in alcoholism treatment today? Not to forget about disulfiram's psychological effects. Addiction 99:26-7
18. Fuller RK, Gordis E. (2004) Does disulfiram have a role in alcoholism treatment today? Addiction 99:21-4
19. Garbutt JC, Kranzler HR, O'Malley SS et al.(2005)Effcacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA 293:1617-25
20. Hughes JC, Cook CC. (1997) The effcacy of disulfiram: a review of outcome studies. Addiction 92:381-95
21. Krampe H, Stawicki S, Wagner T et al. (2006) Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome. Alcohol Clin Exp Res 30:86-95
22. Kranzler HR, Gage A. (2008) Acamprosate effcacy in alcohol-dependent patients: summary of results from three pivotal trials. Am J Addict 17:70-6
23. Kranzler HR, Van Kirk J. (2001) Effcacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res 25:1335-41
24. Laaksonen E, Koski-Jannes A, Salaspuro M et al. (2008) A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 43:53-61
25. Lesch OM, Riegler A, Gutierrez K et al. (2001) The European acamprosate trials: conclusions for research and therapy. J Biomed Sci 8:89-95
26. Mann K. (2004) Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS Drugs 18:485-504
27. Mann K, Ackermann K, Croissant B et al. (2005) Neuroimaging of gender differences in alcohol dependence: are women more vulnerable? Alcohol Clin Exp Res 29:896-901
28. Mann K, Batra A. (1993) Community based management of alcohol dependent patients. Evaluation of a combined inpatient and ambulatory treatment concept. Psychiatr Prax 20:102-5
29. Mann K, Kapp B, Kühnel P et al. (1995) Good estimates for reliability and validity in alcoholics' self reports. Alcohol Alcohol 30:545-5
30. Mann K, Lehert P, Morgan MY. (2004) The effcacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res 28:51-63
31. Mark TL, Kranzler HR, Song X et al. (2003) Physicians' opinions about medications to treat alcoholism. Addiction 98:617-26
32. Mutschler J, Diehl A, Vollmert C et al. (2008) Aktueller Stand der pharmakotherapeutischen Rückfallprophylaxe mit Disulfiram. Neuropsychiatrie 22:243-51
33. Petrakis I, Ralevski E, Nich C et al. VAVISN I MIRECC Study Group (2007) Naltrexone and disulfiram in patients with alcohol dependence and current depression. J Clin Psychopharmacol 27:160-5
34. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes
35. Soyka M, Chick J. (2003) Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective. Am J Addict 12:69-80
36. Verheul R, Lehert P, Geerlings PJ et al. (2005) Predictors of acamprosate effcacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients. Psychopharmacology (Berl) 178:167-73